Bellerophon Therapeutics
BLPH
#11323
Rank
C$0.21 M
Marketcap
C$0.01717
Share price
-36.84%
Change (1 day)
-79.60%
Change (1 year)

Earnings for Bellerophon Therapeutics (BLPH)

Earnings in 2023 (TTM): -C$14.81 Million

According to Bellerophon Therapeutics 's latest financial reports the company's current earnings are C$5.64 Million. In 2022 the company made an earning of -C$32.03 Million a decrease over its 2021 earnings that were of -C$28.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bellerophon Therapeutics from 2014 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$14.81 Million-53.76%
2022 -C$32.03 Million11.03%
2021 -C$28.85 Million-24.22%
2020 -C$38.07 Million52.25%
2019 -C$25 Million-37.33%
2018 -C$39.89 Million13.34%
2017 -C$35.2 Million3.54%
2016 -C$33.99 Million-48.98%
2015 -C$66.63 Million-22.15%
2014 -C$85.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
C$10.32 B-65,510.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.27 Billion 1,594.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
C$0.54 B-3,568.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
-C$0.12 Billion 609.53%๐Ÿ‡บ๐Ÿ‡ธ USA